Compare $MNPR vs $PROK | Chartloom

Compare

$MNPR vs $PROK

Monopar Therapeutics Inc · Prokidney Corp

MNPR

Monopar Therapeutics Inc

PROK

Prokidney Corp

Compare $MNPR vs $PROK

Comparing Monopar Therapeutics Inc and Prokidney Corp

MNPRMonopar Therapeutics Inc

PROKProkidney Corp

MNPRMonopar Therapeutics Inc

Market cap

$529M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

48.37x

Rev growth (TTM)

—

YTD performance

19.6%

52W performance

-19.9%

FCF yield

-2.3%

PROKProkidney Corp

Market cap

$526M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

788.85x

Rev growth (TTM)

55.2%

YTD performance

-22.0%

52W performance

-46.6%

FCF yield

-30.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MNPR

PROK

Detailed metrics comparison

MNPR

Monopar Therapeutics Inc

PROK

Prokidney Corp

Market Cap

MNPR$529M

PROK$526M

Enterprise Value

MNPR$476M

PROK$451M

Price

MNPR$78.96

PROK$1.74

P/E Ratio

MNPRN/A

PROKN/A

P/S Ratio

MNPR0.00x

PROK642.52x

EV/Sales

MNPR0.00x

PROK551.08x

EV/EBITDA

MNPR0.00x

PROK0.00x

P/B Ratio

MNPR4.00x

PROK78.79x

P/FCF Ratio

MNPRN/A

PROKN/A

EV/FCF

MNPR-39.10x

PROK-2.82x

PEG Ratio

MNPRN/A

PROKN/A

Forward P/E (NTM)

MNPRN/A

PROKN/A

Forward P/S (NTM)

MNPR48.37x

PROK788.85x

Revenue (TTM)

MNPR$0

PROK$818K

Revenue Growth (YoY)

MNPRN/A

PROK55.2%

Forward Rev Growth

MNPR327.6%

PROK-44.4%

Gross Margin (TTM)

MNPR0.0%

PROK0.0%

Operating Margin (TTM)

MNPR0.0%

PROK0.0%

EBITDA Margin (TTM)

MNPR0.0%

PROK-20827.6%

Net Margin (TTM)

MNPR0.0%

PROK-10288.4%

FCF Margin (TTM)

MNPRN/A

PROK-19527.4%

Net Income (TTM)

MNPR$-18M

PROK$-84M

FCF (TTM)

MNPR$-12M

PROK$-160M

EPS (TTM)

MNPR-$2.09

PROK-$0.45

ROE (TTM)

MNPR-1308.0%

PROK-2810.2%

ROA (TTM)

MNPR-1279.0%

PROK-2739.0%

ROIC (TTM)

MNPR-1308.0%

PROK0.0%

Cash

MNPR$53M

PROK$75M

Debt

MNPR$0

PROK$67K

Net Cash/Debt

MNPR$53M

PROK$75M

Current Ratio (TTM)

MNPR33.56x

PROK8.36x

Quick Ratio (TTM)

MNPR33.56x

PROK8.07x

Debt/Equity (TTM)

MNPR0.00x

PROK5.40x

Debt/Assets (TTM)

MNPR0.0%

PROK0.0%

Interest Coverage (TTM)

MNPRN/A

PROKN/A

Net Debt/EBITDA (TTM)

MNPR0.00x

PROK0.00x

Beta

MNPR1.54

PROK1.95

52W Performance

MNPR-19.9%

PROK-46.6%

YTD Performance

MNPR19.6%

PROK-22.0%

% from 52W High

MNPR-36.7%

PROK-50.0%

% from 52W Low

MNPR57.7%

PROK33.8%

Asset Turnover (TTM)

MNPR0.00x

PROK0.00x

FCF Yield (TTM)

MNPR-2.3%

PROK-30.4%

Earnings Yield (TTM)

MNPR-3.4%

PROK-16.0%

Dividend Yield (TTM)

MNPRN/A

PROKN/A

Rule of 40

MNPR0.0

PROK-19,472.2

EV/GP/RG

MNPRN/A

PROKN/A

Ticker research

View MNPR research View PROK research

Metric	MNPR Monopar Therapeutics Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$529M	$526M
Enterprise Value	$476M	$451M
Price	$78.96	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	642.52x
EV/Sales	0.00x	551.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.00x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-39.10x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	48.37x	788.85x
Revenue & Growth
Revenue (TTM)	$0	$818K
Revenue Growth (YoY)	N/A	55.2%
Forward Rev Growth	327.6%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20827.6%
Net Margin (TTM)	0.0%	-10288.4%
FCF Margin (TTM)	N/A	-19527.4%
Net Income (TTM)	$-18M	$-84M
FCF (TTM)	$-12M	$-160M
EPS (TTM)	-$2.09	-$0.45
ROE (TTM)	-1308.0%	-2810.2%
ROA (TTM)	-1279.0%	-2739.0%
ROIC (TTM)	-1308.0%	0.0%
Financial Health
Cash	$53M	$75M
Debt	$0	$67K
Net Cash/Debt	$53M	$75M
Current Ratio (TTM)	33.56x	8.36x
Quick Ratio (TTM)	33.56x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.95
52W Performance	-19.9%	-46.6%
YTD Performance	19.6%	-22.0%
% from 52W High	-36.7%	-50.0%
% from 52W Low	57.7%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-2.3%	-30.4%
Earnings Yield (TTM)	-3.4%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View MNPR research	View PROK research

Valuation

P/S Ratio

MNPR

0.00x

PROK

642.52x

EV/FCF

MNPR

-39.10x

PROK

-2.82x

Growth & revenue

Revenue Growth TTM

PROK

55.2%

Forward Revenue Growth

MNPR

327.6%

PROK

-44.4%

Profitability & performance

Gross Margin

MNPR

0.0%

PROK

0.0%

ROE

MNPR

-1308.0%

PROK

-2810.2%

FCF Yield %

MNPR

-2.3%

PROK

-30.4%

52-Week Performance

MNPR

-19.9%

PROK

-46.6%

Detailed metrics comparison

MNPR

Monopar Therapeutics Inc

PROK

Prokidney Corp

Market Cap

MNPR$529M

PROK$526M

Enterprise Value

MNPR$476M

PROK$451M

Price

MNPR$78.96

PROK$1.74

P/E Ratio

MNPRN/A

PROKN/A

P/S Ratio

MNPR0.00x

PROK642.52x

EV/Sales

MNPR0.00x

PROK551.08x

EV/EBITDA

MNPR0.00x

PROK0.00x

P/B Ratio

MNPR4.00x

PROK78.79x

P/FCF Ratio

MNPRN/A

PROKN/A

EV/FCF

MNPR-39.10x

PROK-2.82x

PEG Ratio

MNPRN/A

PROKN/A

Forward P/E (NTM)

MNPRN/A

PROKN/A

Forward P/S (NTM)

MNPR48.37x

PROK788.85x

Revenue (TTM)

MNPR$0

PROK$818K

Revenue Growth (YoY)

MNPRN/A

PROK55.2%

Forward Rev Growth

MNPR327.6%

PROK-44.4%

Gross Margin (TTM)

MNPR0.0%

PROK0.0%

Operating Margin (TTM)

MNPR0.0%

PROK0.0%

EBITDA Margin (TTM)

MNPR0.0%

PROK-20827.6%

Net Margin (TTM)

MNPR0.0%

PROK-10288.4%

FCF Margin (TTM)

MNPRN/A

PROK-19527.4%

Net Income (TTM)

MNPR$-18M

PROK$-84M

FCF (TTM)

MNPR$-12M

PROK$-160M

EPS (TTM)

MNPR-$2.09

PROK-$0.45

ROE (TTM)

MNPR-1308.0%

PROK-2810.2%

ROA (TTM)

MNPR-1279.0%

PROK-2739.0%

ROIC (TTM)

MNPR-1308.0%

PROK0.0%

Cash

MNPR$53M

PROK$75M

Debt

MNPR$0

PROK$67K

Net Cash/Debt

MNPR$53M

PROK$75M

Current Ratio (TTM)

MNPR33.56x

PROK8.36x

Quick Ratio (TTM)

MNPR33.56x

PROK8.07x

Debt/Equity (TTM)

MNPR0.00x

PROK5.40x

Debt/Assets (TTM)

MNPR0.0%

PROK0.0%

Interest Coverage (TTM)

MNPRN/A

PROKN/A

Net Debt/EBITDA (TTM)

MNPR0.00x

PROK0.00x

Beta

MNPR1.54

PROK1.95

52W Performance

MNPR-19.9%

PROK-46.6%

YTD Performance

MNPR19.6%

PROK-22.0%

% from 52W High

MNPR-36.7%

PROK-50.0%

% from 52W Low

MNPR57.7%

PROK33.8%

Asset Turnover (TTM)

MNPR0.00x

PROK0.00x

FCF Yield (TTM)

MNPR-2.3%

PROK-30.4%

Earnings Yield (TTM)

MNPR-3.4%

PROK-16.0%

Dividend Yield (TTM)

MNPRN/A

PROKN/A

Rule of 40

MNPR0.0

PROK-19,472.2

EV/GP/RG

MNPRN/A

PROKN/A

Ticker research

View MNPR research View PROK research

Metric	MNPR Monopar Therapeutics Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$529M	$526M
Enterprise Value	$476M	$451M
Price	$78.96	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	642.52x
EV/Sales	0.00x	551.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.00x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-39.10x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	48.37x	788.85x
Revenue & Growth
Revenue (TTM)	$0	$818K
Revenue Growth (YoY)	N/A	55.2%
Forward Rev Growth	327.6%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20827.6%
Net Margin (TTM)	0.0%	-10288.4%
FCF Margin (TTM)	N/A	-19527.4%
Net Income (TTM)	$-18M	$-84M
FCF (TTM)	$-12M	$-160M
EPS (TTM)	-$2.09	-$0.45
ROE (TTM)	-1308.0%	-2810.2%
ROA (TTM)	-1279.0%	-2739.0%
ROIC (TTM)	-1308.0%	0.0%
Financial Health
Cash	$53M	$75M
Debt	$0	$67K
Net Cash/Debt	$53M	$75M
Current Ratio (TTM)	33.56x	8.36x
Quick Ratio (TTM)	33.56x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.95
52W Performance	-19.9%	-46.6%
YTD Performance	19.6%	-22.0%
% from 52W High	-36.7%	-50.0%
% from 52W Low	57.7%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-2.3%	-30.4%
Earnings Yield (TTM)	-3.4%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View MNPR research	View PROK research